Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04650984
Title A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma (FIBROSARC)
Acronym FIBROSARC
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Philogen S.p.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | ITA | FRA | ESP | DEU


No variant requirements are available.